Table 2.
Cervical Cancer (CC) Incidence Rate in Asia from 2003-2007 Based on Available Population-Based Cancer Registries from International Agency for Research on Cancer, and Cervical Cancer Prevention Programmes
| Country based on WHO regional offices | No. of CC cases | Frequency of CC (%) | Crude rate/ 100,000 | ASR/ 100,000 | HPV vaccination program | Estimated coverage of cervical cancer screening (%) |
|---|---|---|---|---|---|---|
| Eastern Mediterranean | ||||||
| Bahrain | 44 | 3.7 | 3.9 | 5.7 | No | 43.1 |
| Kuwait | 161 | 4.1 | 3 | 4.6 | No | 22.3 |
| Islamic Republic of Iran, (Golestan Province) | 91 | 3.8 | 3.7 | 5.4 | No | 49.4 |
| Israel | 918 | 1.6 | 5.5 | 5 | National | 32 |
| Qatar | 17 | 3.6 | 3.4 | 5.3 | No | 39.4 |
| Saudi Arabia | 103 | 1.9 | 1.1 | 2 | No | No data |
| Western Pacific | ||||||
| ^China | 40-2,080 | 1.8-27.1 | 4.2-78.2 | 2.6-71.8 | No | 17.2 |
| ^Japan | 264-2,509 | 2.2-3.4 | 10.0-15.0 | 6.9-10.2 | *National | 31.5 |
| Republic of Korea | 20,234 | 6.2 | 16.7 | 12.5 | No | 76.2 |
| Singapore | 1,013 | 4.6 | 11.6 | 8.9 | Private sector | 47.9 |
| Philippines (Manila and Rizal) | 1,991-2,008 | 8.9-9.2 | 12.1-13.4 | 16.6-17.0 | National | 7.7 |
| Malaysia (Penang) | 342 | 8.4 | 12.2 | 12.5 | National | 22.2 |
| South-East Asia | ||||||
| ^Thailand | 459-3,214 | 11.1-18.0 | 14.0-32.0 | 11.8-26.1 | Pilot | 60.2 |
| ^India | 87-4280 | 8.8-36.4 | 6.5-24.1 | 8.9-24.5 | Pilot | 4.9 |
Source of data: (Forman D and E, 2014);
*
suspended in 2013 (<1% coverage);
ASR, Age-standardised rate; No., number; ^CC incidence rates based on cancer registry from multiple cities within the country